Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Gross Profit (2023 - 2025)

Bioregenx (BRGX) has 3 years of Gross Profit data on record, last reported at $426397.0 in Q3 2025.

  • For Q3 2025, Gross Profit fell 11.47% year-over-year to $426397.0; the TTM value through Sep 2025 reached $1.5 million, down 12.03%, while the annual FY2024 figure was $1.7 million, 28.25% down from the prior year.
  • Gross Profit reached $426397.0 in Q3 2025 per BRGX's latest filing, up from $352455.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $763891.0 in Q1 2023 and bottomed at $322737.0 in Q4 2024.
  • Average Gross Profit over 3 years is $468612.0, with a median of $426397.0 recorded in 2025.
  • Peak YoY movement for Gross Profit: crashed 49.71% in 2024, then rose 5.69% in 2025.
  • A 3-year view of Gross Profit shows it stood at $378025.0 in 2023, then decreased by 14.63% to $322737.0 in 2024, then skyrocketed by 32.12% to $426397.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $426397.0 in Q3 2025, $352455.0 in Q2 2025, and $406031.0 in Q1 2025.